Condition: Human Papilloma Virus · Sponsor: Labo'Life
Human papillomavirus (HPV) is a prevalent pathogen, the epidemiology of which has mostly been studied in the uterine cervix and the vagina. The KCE Report 238Cs (2015) recommends " HR-HPV-positive women should not be offered colposcopy immediately. Triage should be done using cytology for this purpose. If cytological abnormalities (ASCUS+) are found, immediate referral should follow for diagnosis and, where appropriate, treatment. If no abnormalities are observed in triage, the subject should be offered follow-up testing (cytology) at six months. ". There is no treatment that is recommended during this lap time. The 2LPAPI® has been available for more than 20 years, and has received a marketing authorization in Belgium by the FAMHP. It is used as an immune regulator in the treatment of HR-HPV infections. Since 2LPAPI® has been made available, clinical observational data collected on treated patients have shown the beneficial effect on the clearance of HPV. The purpose of this placebo-controlled trial is to evaluate the efficacy of 2LPAPI® on the clearance of genital HR-HPV infections.
This description comes directly from the study's public registry record.
Laura FERTE · +32499717964 · laura.ferte@labolife.com
Charlotte BOLLE · charlotte.bolle@labolife.com
Always discuss trial participation with your own doctor first.
| CHU Saint-Pierre | Brussels, Belgium | Recruiting |
| Clinique St Jean | Brussels, Belgium | Recruiting |
| CHU Brugmann | Brussels, Belgium | Recruiting |
| Hôpitaux Iris Sud - Iris Zuid Ziekenhuis | Brussels, Belgium | Recruiting |
| Hôpital Civil Marie Curie ISPPC | Charleroi, Belgium | Active Not Recruiting |
| Centre Hospital Reine Astrid Malmedy (CHRAM) | Malmedy, Belgium | Active Not Recruiting |
| Belgium | Namur, Belgium | Recruiting |
| Belgium | Namur, Belgium | Active Not Recruiting |
| Cabinet privé | Namur, Belgium | Recruiting |
| UCL Namur - site Sainte Elisabeth | Namur, Belgium | Recruiting |
| Clinique Saint-Pierre Ottignies (CSPO) | Ottignies, Belgium | Not Yet Recruiting |
| CHWAPI | Tournai, Belgium | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04232917